Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
National Institute of General Medical Sciences (R35 GM118062)
Text and Data Mining valid from 2019-05-20
Received: 1 November 2018
Accepted: 11 April 2019
First Online: 20 May 2019
Change Date: 10 June 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
: The authors declare competing financial interests. D.R.L. is a consultant and cofounder of Editas Medicine, Pairwise Plants and Beam Therapeutics, companies that use genome editing. The authors have filed patent applications on base editors with altered targeting properties. The authors declare no competing non-financial interests.